STOK
Stoke Therapeutics, Inc.
Pharmaceutical Preparations- 売上
- $184m
- 時価総額
- $1.7bn
株価 $29.39 · 100株 2,939円
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $9m | $37m | $184m |
| 成長率 | — | 316.4% | 404.4% |
| 総利益 | — | — | — |
| 総利益率 | — | — | — |
| 販管費 | — | $49m | $67m |
| 販管費率 | — | 133.5% | 36.4% |
| 営利 | ▲$115m | ▲$101m | ▲$21m |
| 営利率 | ▲1,307.2% | ▲277.3% | ▲11.2% |
| 純利益 | ▲$105m | ▲$89m | ▲$7m |
| PBR | 10.9 | 7.6 | 4.9 |
| PSR | 197.2 | 47.4 | 9.4 |
| PGPR | — | — | — |
| PER | — | — | — |
| ネットキャッシュ | $191m | $128m | $84m |
| EV/EBITDA | — | — | — |
| Rule of 40 | — | 39% | 393% |
| セールス効率 | — | — | — |
※Rule of 40は売上成長率+営業利益率、セールス効率は売上総利益増加÷販管費増加(販管費増のときのみ)
